Form F-10/A - Registration Statement for Securities of certain Canadian Issuers.: [Amend]
SEC Accession No. 0001144204-14-046358
Filing Date
2014-08-01
Accepted
2014-08-01 13:23:47
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM F-10/A v385434_f10a.htm F-10/A 235009
2 GRAPHIC image_001.jpg GRAPHIC 4562
3 GRAPHIC image_002.gif GRAPHIC 6411
4 GRAPHIC image_002.jpg GRAPHIC 17961
5 GRAPHIC image_003.jpg GRAPHIC 15398
6 EXHIBIT 5.1 v385434_ex5-1.htm EX-5.1 3162
7 GRAPHIC image_001.gif GRAPHIC 1712
  Complete submission text file 0001144204-14-046358.txt   303298
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-10/A | Act: 33 | File No.: 333-197633 | Film No.: 141009242
SIC: 2834 Pharmaceutical Preparations